Host microRNAs exhibit differential propensity to interact with SARS-CoV-2 and variants of concern

• Published in: Biochimica et biophysica acta. Molecular basis of disease 2023-02, Vol.1869 (2), p.166612-166612, Article 166612
• Main Authors: Capistrano, Kristelle J., Richner, Justin, Schwartz, Joel, Mukherjee, Sunil K., Shukla, Deepak, Naqvi, Afsar R.
• Format: Article
• Language: English
• Subjects: Antiviral immunity; COVID-19; Gene Expression Profiling; Humans; MicroRNAs; MicroRNAs - genetics; Post-transcriptional regulation; SARS-CoV-2; SARS-CoV-2 - genetics; Variants of concern
• ISSN: 0925-4439; 1879-260X
• DOI: 10.1016/j.bbadis.2022.166612

A significant number of SARS-CoV-2-infected individuals naturally overcome viral infection, suggesting the existence of a potent endogenous antiviral mechanism. As an innate defense mechanism, microRNA (miRNA) pathways in mammals have evolved to restrict viruses, besides regulating endogenous mRNAs. In this study, we systematically examined the complete repertoire of human miRNAs for potential binding sites on SARS-CoV-2 Wuhan-Hu-1, Beta, Delta, and Omicron. Human miRNA and viral genome interaction were analyzed using RNAhybrid 2.2 with stringent parameters to identify highly bonafide miRNA targets. Using publicly available data, we filtered for miRNAs expressed in lung epithelial cells/tissue and oral keratinocytes, concentrating on the miRNAs that target SARS-CoV-2 S protein mRNAs. Our results show a significant loss of human miRNA and SARS-CoV-2 interactions in Omicron (130 miRNAs) compared to Wuhan-Hu-1 (271 miRNAs), Beta (279 miRNAs), and Delta (275 miRNAs). In particular, hsa-miR-3150b-3p and hsa-miR-4784 show binding affinity for S protein of Wuhan strain but not Beta, Delta, and Omicron. Loss of miRNA binding sites on N protein was also observed for Omicron. Through Ingenuity Pathway Analysis (IPA), we examined the experimentally validated and highly predicted functional role of these miRNAs. We found that hsa-miR-3150b-3p and hsa-miR-4784 have several experimentally validated or highly predicted target genes in the Toll-like receptor, IL-17, Th1, Th2, interferon, and coronavirus pathogenesis pathways. Focusing on the coronavirus pathogenesis pathway, we found that hsa-miR-3150b-3p and hsa-miR-4784 are highly predicted to target MAPK13. Exploring miRNAs to manipulate viral genome/gene expression can provide a promising strategy with successful outcomes by targeting specific VOCs. •Hundreds of human miRs have putative binding sites on SARS-CoV-2 VOC genomes.•VOCs, particularly Omicron, evade miR binding sites identified in Wuhan-Hu-1.•SARS-CoV-2 targeting miRs regulate immune pathways, suggesting antiviral functions.